Streptococcus pneumoniae type 1 capsular polysaccharide antigen Completed Phase 3 Trials for Pneumococcal Infectious Diseases Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT02285036Safety and Immunogenicity of a Newly 23-valent Pneumococcal Polysaccharide Vaccine in Chinese Adults and Children